CAPO Award

Award for Excellence in Psychosocial Oncology

This annual award is presented to a member of the Canadian Association of Psychosocial Oncology (CAPO) to acknowledge the important work of psychosocial oncology professionals. CAPO members are invited to submit abstracts, for the annual CAPO conference. Abstracts may reflect clinical practice, education or research related to the neuro-oncology population.

Award Amount: $1,500.00 (along with a framed recognition certificate)

2018 CAPO Award Winner

2018 CAPO Award WinnerCongratulations to Leandra Desjardins, Aden Solomon, Laura Janzen, Ute Bartels, Fiona Schulte, Joanna Chung, Danielle Cataudella, and Maru Barrera, winners of the 2018 CAPO Award for their research entitled: The Association Between Executive Functions and Social Skills in Pediatric Brain Tumour Survivors: Let's Get Specific

The findings of this study highlight the importance of assessing different perspectives of pediatric brain tumour survivors' social competence, as well as understanding the specific processes underlying perceived social skills deficits. 

Pictured: Alan Bates and Leandra Desjardins

2017 CAPO Award Winner

Dr. Tom Hack - CAPO Award Winner

Congratulations to Dr. Tom Hack! 

Tom was involved in a randomized controlled trial of consultation recording use to enhance psychosocial wellbeing and coping behaviour in patients with brain tumours.

Thomas F Hack, PhD
Director, Psychosocial Oncology & Cancer Nursing Research, I.H. Asper Clinical Research Institute, Senior Scientist, Research Institute in Oncology and Hematology at CancerCare Manitoba, Professor, College of Nursing, Rady Faculty of Health Sciences, University of Manitoba, Visiting Professor, University of Central Lancashire, Preston, UK

Pictured: Todd Goold - Brain Tumour Foundation of Canada, Dr. Tom Hack and CAPO Vice President Dr. Fiona Schulte

2016 CAPO Award Winner

Mark Collins CAPO Award Winner 2016

Congratulations to Mark Collins!

The research was titled: “Predicting survival of individuals with high-grade brain tumours using neuropsychological test measures”

By Mark Collins and co-author Dr. Mariani 

Pictured: Mark Collins receiving his award from Todd Goold, Brain Tumour Foundation of Canada 
 

2015 CAPO Award Winners

Dr Ozier with his recipient certificateCongratulations to the 2015 recipients (in order of authorship): Dr. Douglas Ozier (PhD), Dr. Matias Mariani (PhD) and Maureen Parkinson (M.Ed., C.C.R.C.).

Dr Ozier and Maureen Parkinson are affiliated with: BC Cancer Agency, Provincial Psychosocial Oncology, Vancouver, BC.

Dr. Mariani is affiliated with: Supportive Care Program and Supportive Care Oncology Research Unit, Health Sciences North, Sudbury, ON.

Their research was titled, "A remote intervention to improve emotional and cognitive functioning in brain tumour survivors."

Pictured: Dr Douglas Ozier holding his recognition certificate.

2014 CAPO Award Winner

Douglas Ozier CAPO award winner with Koye Oyerinde of Brain Tumour Foundation of CanadaCongratulations to Dr. Douglas Ozier, the recipient of the 2014 CAPO Award.

The research was titled, ""Heart Rate Variability Biofeedback for Anxiety and Depression in Primary Malignant Brain Tumour Patients."
 

Pictured: Dr. Douglas Ozier (left) and Koye Oyerinde, Support Services Specialist at Brain Tumour Foundation of Canada. Photo courtesy of CAPO.


 

2013 CAPO Award Winner

Congratulations to Dr. Matias Mariani, the recipient of the 2013 CAPO Award.

Dr. Mariani's research was titled, “Neuropsychological profiles in individuals with brain tumours”.

2012 CAPO Award Winner

Congratulations to Maureen Parkinson, the recipient of the 2012 CAPO Award.

Her research was titled, “Changes in quality of life, functional activities and cognitive function from baseline to six-months post-treatment for patients with high grade gliomas."

 

 

 

2011 CAPO Award Winner

Congratulations to Dr. Matias Mariani, the recipient of the 2011 CAPO Award.

Dr. Mariani's research was titled, "Aphasia in patients with primary brain tumours: A neuropsychological approach."

Cognitive impairments significantly affect the quality of life of patients undergoing or having completed cancer treatment. Although cognitive deficits may be present as adverse effects of treatment to other cancer sites, the most substantial deficits are observed in patients with brain tumours. Language deficits are common among those affected by brain tumours and tend to be associated with declines in communication, mood and ability to perform activities of daily living. A neuropsychological assessment serves to evaluate and quantify functioning issues leading to an optimized treatment plan.

This presentation outlines the neuropsychological profiles of 5 patients with left-sided primary brain tumours.

The goals are as follows:

  • To review the classification of aphasia syndromes.
  • To provide framework for evaluating language disorders via neuropsychological assessment.
  • To differentiate between various disorders that present with communication problems.
  • To provide strategies to rehabilitate cognitive deficits (including language) and improve quality of life in patients with primary brain tumours.

2010 CAPO Award Winner

Congratulations to the recipient of the 2010 award: Dr. Kim Edelstein, a Neuropsychologist with Princess Margaret Hospital for her work researching the neurocognitive late effects of treatment in adult survivors of childhood cancer.

2009 CAPO Award Winners

Congratulations to the recipients of the 2009 award: Dr. Robert Olson, Hannah Carolan, Ann-Lousie Ellwood, Maureen Parkinson, Kyle Ferguson, Dr. Grant Iverson and Michael McKenzie for their research, Comparison of Two Cognitive Screening Measures, the Mini Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA), in patients with brain tumours.

Identifying cognitive impairment is important in patients with brain tumours. Because neuropsychological evaluations are usually not available, brief screening measures are often used. The Mini Mental State Examination (MMSE) is most commonly employed, despite no validation in this setting. The Montreal Cognitive Assessment (MoCA) is an alternative. In this study, the research team compared the sensitivity and specificity of these screening measures for identifying cognitive impairment.

The recent Canadian Association of Psychosocial Oncology Conference was held in Vancouver, British Columbia during the week of April 1st, 2009. Congratulations and thank you so much to all of the psychosocial oncology professionals who do so much in the fight against brain tumours.

2008 CAPO Award

In May 2008 Brain Tumour Foundation of Canada Award in support of Psychosocial Oncology Excellence was presented to Dr. Guy Pelletier and Tracey Wornsbecker at the Canadian Association of Psychosocial Oncology national conference.

The duo received their award for their research entitled, Quality of Life of Spousal Caregivers of Primary Malignant Brain Tumour Patients. The cross-sectional study documented negative outcomes such as emotional distress and relationship adjustment problems experienced by the spouses of patients with primary malignant brain tumours and also explored the determinants of the problems and the extent to which they correlated with each other.Congratulations to Dr. Pelletier and Ms. Wornsbecker.

< Back to HCP Awards

Share This

Featured Story

Hats for Hope

Today, 8 Canadians will learn they have brain cancer. That's 3,000 Canadians each year. That's why we have launched Hats for Hope a nation-wide brain cancer awareness campaign and are calling on all Canadians to pledge support for brain cancer research. Join us in International Brain Tumour Awareness Week, October 20 - 27, 2018, or on October 24, 2018 – the first Brain Cancer Awareness Day in Canada – by wearing a hat, taking a selfie or group photo, and sharing it on social using #HatsForHope

Learn more

Spotlight

Childhood Brain Tumour Signs & Symptoms

Earlier this year, you gave us your feedback in a survey on brain tumour signs and symptoms. One of the things we did with that survey...

Learn more

Anthony's Story is Our Story

I would like to take the opportunity to share "our" story. It’s actually my best friend Anthony's story, but I use the term "our"...

Learn more

Upcoming Events

  • 24/Oct/2018: Ottawa Support Group: Meets at the Maplesoft Centre at 1500 Alta Vista Drive, Ottawa, ON.... Learn more >
  • 25/Oct/2018: Virtual Support Group East: Virtual Support Group for Eastern Canada... Learn more >
  • 27/Oct/2018: National Conference - Montreal: Hôtel Ruby Foo's, Montreal, QC & diffusion en direct... Learn more >
  • 27/Oct/2018: SUPERKIDS - A Quest to End Brain Tumours: CitiPlaza, London, ON... Learn more >
View All Events >
Thank you to the donors whose contributions make this website and all programs, services and research possible.

Copyright © 2018 Brain Tumour Foundation of Canada. Charitable Registration #BN118816339RR0001